Skip to main content

Table 2 Correlation analysis between FF NAM and IVF cycle characteristics

From: Effects of nicotinamide on follicular development and the quality of oocytes

Parameters

Values

r

P

NAM (μg/L)

51.52 ± 2.23

  

Age (years)

32.16 ± 0.40

0.028

0.698

BMI (kg/m2)

22.54 ± 0.24

− 0.077

0.295

AFC (n)

15.29 ± 0.52

− 0.037

0.613

Basal LH (mIU/ml)

4.64 ± 0.22

− 0.052

0.475

Basal FSH (mIU/ml)

9.13 ± 0.37

− 0.021

0.776

AMH (ng/ml)

3.24 ± 0.21

− 0.012

0.873

Basal E2 (pg/ml)

48.36 ± 3.27

0.064

0.385

Gn duration (days)

10.75 ± 0.22

− 0.056

0.445

Gn dose (IU)

2358.82 ± 58.14

−0.059

0.417

E2 on HCG day (pmol/L)

3963.26 ± 271.00

0.082

0.264

Progesterone on HCG day (nmol/L)

1.04 ± 0.06

0.083

0.259

LH on HCG day (IU/L)

1.92 ± 0.20

0.042

0.570

FSH on HCG day (IU/L)

15.54 ± 0.32

0.038

0.608

Oocytes retrieved (n)

11.01 ± 0.62

0.065

0.372

Mature oocytes (n)

8.19 ± 0.49

0.121

0.095

Oocyte maturation rate (%)

74.59 ± 1.75

0.173

0.018*

Fertilization rate (%)

74.30 ± 1.75

0.165

0.024*

Cleavage rate (%)

95.44 ± 1.33

0.013

0.861

High-quality embryo rate (%)

49.75 ± 2.31

−0.024

0.744

Clinical pregnancy rate (%)

49.18 ± 3.44

0.060

0.429

  1. *Values are significantly different between groups (P < 0.05)